LogicBio Therapeutics

LogicBio Therapeutics is a pioneering biotechnology research company dedicated to developing innovative genetic medicines, particularly in the realm of rare pediatric diseases. With a focus on advancing medical science, LogicBio Therapeutics is committed to addressing critical healthcare challenges through cutting-edge research and development. The company's location at 65 Hayden Ave, Lexington, Massachusetts 02421, US, serves as a central hub for its operations.

LogicBio Therapeutics is at the forefront of biotechnology, striving to make a significant impact on patient outcomes. By focusing on rare pediatric diseases, LogicBio Therapeutics is dedicated to delivering hope and potential cures to those who need it most. The company continuously seeks to expand its capabilities and broaden its therapeutic reach within the biotechnology sector.

LogicBio Therapeutics is dedicated to excellence in biotechnology and is committed to improving the lives of patients through genetic medicine innovation. We invite the management team to enhance this profile further by creating a customized and exclusive company showcase and product listing on our platform. This will provide a comprehensive view of LogicBio Therapeutics' capabilities and contributions to the field.